Valco Instruments is partnering with The Gabriel Institute and IsoTherapeutics Group, LLC to pursue pioneering work in liquid brachytherapy – the direct administration of therapeutic isotopes into tumors. Currently the focus is on a clinical trial treating canine osteosarcoma at the Texas A&M Institute for Pre-Clinical Studies.
The Gabriel Institute was started by VICI founder Stan Stearns after his St. Bernard friend Gabe succumbed from complications related to osteosarcoma in January of 2008. Research to determine the best available treatment led to the realization that VICI's years of experience in designing and manufacturing components for delivering, sampling, and detecting trace components could be applied to devising equipment for localizing the delivery of concentrations of chemotherapeutic, radiochemical, and radiation therapies.
